Overview

Antimicrobial Prophylaxis in Thyroid and Parathyroid Surgery

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
0
Participant gender:
All
Summary
The effectiveness of antimicrobial prophylaxis (AMP) for prevention of surgical site infection (SSI) following thyroid and parathyroid surgery remains uncertain. Present prospective randomized control study (Ito-RCT1) assessed the effectiveness of AMP in clean neck surgery associated with thyroid and parathyroid disease.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Ito Hospital
Treatments:
Anti-Infective Agents
Cefazolin
Piperacillin
Criteria
Inclusion Criteria:

- Between November 2010 and April 2012, 2164 consecutive patients who agreed to attend
the randomized control study were enrolled. All the participants received surgery for
thyroid and parathyroid disease at Ito Hospital.

Exclusion Criteria:

- Patients who did not agree to attend the randomized control study.

- Patients who received the operation including mediastinum with sternotomy.

- Patients who received the operation including additional resection of trachea,
esophagus and larynx.

- Patients who received the re-operation for post-operative bleedings.

- Patients who had known allergy to cephem or penicillin.